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ABSTRACT 
Depressed mood is the most common psychiatric disorder following stroke 
with estimated prevalence rates ranging anywhere from 20% to 60%. It has 
been reported that effective and rapid treatment of poststroke depression may 
enhance stroke rehabilitation and speed up functional recovery. The potential 
reversibility of depression emphasizes the importance of early identification of 
poststroke depression. Yet, poststroke depression remains largely untreated as 
part of the rehabilitation process. Therefore, it is important that health 
professionals, such as physical therapists, who often work with patients who 
have suffered a stroke are aware of the signs and symptoms of poststroke 
depression to ensure correct treatment. 
The purpose of this study is to conduct a literature search to: 1) provide a 
basic understanding of the signs and symptoms of poststroke depression, 2) 
review the three major theories to explain depression based on 
neuropharmacology, neuroendocrinology, and neuroanatomy including lesion 
location, 3) describe the effects of poststroke depression on rehabilitation gains 
both short and long term, and 4) explain the effects of pharmacotherapy, 
electroconvulsive therapy (ECT), and psychotherapy used when treating 




Stroke represents a major cause of disability and death in the United 
States as an estimated 500,000 Americans have a stroke each year.1 
Presently, 80% of stroke victims survive one month and the number of survivors 
continues to increase due to improved acute care.1 Following stroke, the 
survivors typically present with varying degrees of physical and cognitive 
disabilities. Recent literature has reported that psychiatric disorders, specifically 
poststroke depression, may be a common sequela of stroke. 
Depressed mood is the most common psychiatric disorder following 
stroke with estimated prevalence rates ranging anywhere from 20% to 60%.2,3,4 
These rates vary depending on the study population characteristics, such as 
inpatient or community setting, and also on the method of defining poststroke 
depression.3 The prevalence of poststroke depression also appears to depend 
on the time poststroke. A study by Robinson and Prices reported that the 
prevalence of poststroke depression increases significantly for patients between 
six months and two years poststroke. The same study found that patients who 
were ten or more years poststroke typically have more depressive symptoms 
than those between two and ten years. Astrom et al6 found a similar trend. 
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The authors reported the presence of a major depressive syndrome in 25% of 
the 50 patients sampled at discharge from a stroke unit. The prevalence 
decreased up to one year (12%), but thereafter occurred more often so that at 
three years poststroke, 25% of the long term sUNivors were depressed. 
Untreated poststroke depression has been found to last from 
approximately eight to nine months.2,5 Because of this, it is likely that patients 
with poststroke depression will seem depressed at discharge from a hospital or 
rehabilitation center,2 and this will continue as they try to adjust both physically 
and emotionally to returning to their previous lifestyle. The presence of 
depression adds to the complexities and multiplies the problems of the 
readjustment process. The potential reversibility of depression emphasizes the 
importance of early identification of poststroke depression? It has been 
reported that effective and rapid treatment of poststroke depression may 
enhance stroke rehabilitation and speed up functional recovery2,3,8 both during 
the hospital stay and over the two year recovery period. 9 Therefore, it is 
important that health professionals, such as physical therapists, who often work 
with patients who have suffered a stroke are aware of the signs and symptoms 
of poststroke depression to ensure correct treatment. 
However, poststroke depression remains largely untreated as part of the 
rehabilitation process.2,?,8,10 A study conducted by Feibel and Springer? 
evaluated 91 patients at six months poststroke. They found only five had 
received treatment for depression, although 24 (26%) of those patients showed 
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significant depression symptoms. There are several possibilities as to why 
patients suffering from depression following stroke are not commonly treated: 
(a) acceptance of depression as an inevitable grief reaction, (b) lack of 
awareness of the increased risk of depression for patients who have sUNived a 
stroke, and (c) lack of information about the characteristics and course of 
depressive disorders.5 
The purpose of this paper is to: 
1. Provide a basic understanding of the signs and symptoms of 
poststroke depression. 
2. Review the three major theories to explain depression based on 
neuropharmacology, neuroendocrinology, and neuroanatomy 
including lesion location. 
3. Describe the effects of poststroke depression on rehabilitation gains 
both short and long term. 
4. Explain the effects of pharmacotherapy, electroconvulsive therapy or 
ECT, and psychotherapy used when treating patients suffering from 
poststroke depression. 
CHAPTER 2 
DEFINING POSTSTROKE DEPRESSION 
The term depression has two distinct definitions. First, depression can 
be a symptom, such as sadness or disinterest in life activities. The term 
depression also refers to a full clinical syndrome or illness with a variety of 
accompanying symptoms.1 Throughout the course of this paper, depression will 
be used to describe the illness of major or minor depression. 
When classifying depression as either major or minor, this does not 
necessarily mean one is worse than the other. Dysthymia or minor depression 
is a form of clinical depression that is characterized by its chronic nature and 
lack of physical symptoms of depression. 11 Because of the lack of physical 
symptoms, it may go unnoticed and left untreated moreso than major 
depression. It is also important to note the chronicity associated with minor 
depression. Robinson et al5 found major depressive illness usually resolves 
spontaneously within two years of the stroke, whereas minor depression lingers 
for a longer period. Because of these characteristics, the classification of major 
or minor depressive illness will not necessarily tell if it has a major or minor 
effect on rehabilitation and community re-entry.1 
4 
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Depression may also be classified as either primary or secondary.1 
Primary major depressive disorder, also called functional unipolar depression, 
and secondary major depressive illness share the same clinical syndrome. The 
difference is that secondary depressive illness has identifiable, causative factors 
from the history, examination, or laboratory findings whereas the patient who 
has primary depressive illness often presents with a family history of depressive 
illness, typical clinical course, prognosis, and treatment response. Therefore, 
poststroke depression can be identified as a secondary depressive disorder.1 
One of the ways most commonly used to classify depressive illness is 
according to the American Psychiatric Association's Diagnostic and Statistical 
Manual, edition 3, known as the DSM 11112 or, in more recent years, the revised 
edition 3 or DSM III-R.13 Depressive changes are usually classified to the DSM 
categories of "major depressive episode" and "dysthymic disorder" also known 
as minor depression. These depressive episodes are diagnosed based on the 
presence or absence of the definable symptoms presented in Tables 1 and 2.13 
In accordance with the DSM III-R, Clothier and Grotta1 described the 
three areas where symptoms of depressive illness are evident: affective 
regulation, cognition, and somatic concerns. The affective disorder in 
depressive illness typically includes reduced reactivity of mood noticeable as 
withdrawal from rewarding behaviors, and appears as social isolation, 
anhedonia, crying spells, and general lassitude or exhaustion. Cognitive 
complaints may include poor concentration and effort, persistent feelings of 
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Table 1. Diagnostic Criteria for Major Depressive Episode 
A. At least five of the following during a two-week period representing a 
change from previous functioning; at least one of the symptoms must 
be either depressed mood or loss of interest and pleasure. 
1. Depressed mood most of the day, nearly every day. 
2. Markedly diminished interest or pleasure in all, or almost all 
activities. 
3. Significant weight loss or gain when not dieting, or decrease or 
increase in appetite nearly every day. 
4. Insomnia or hypersomnia. 
5. Psychomotor agitation or retardation. 
6. Fatigue or loss of energy nearly every day. 
7. Feelings of worthlessness or excessive or inappropriate guilt nearly 
every day (may be to a delusional extent). 
8. Diminished concentration or ability to think, or by indecisiveness, 
nearly every day. 
9. Recurrent thoughts of death, recurrent suicidal ideations, or suicide 
plan or attempt. 
B. Criteria for functional depression 
1. It cannot be established that an organic factor initiated and 
maintained the disturbance. 
2. The disturbance is not a normal reaction to the death of a loved one. 
C. At no time during the disturbance have there been delusions or 
hallucinations for as long as two weeks in the absence of prominent 
mood symptoms. 
D. Not superimposed on schizophrenia, schizophreniform disorder, 
delusional disorder, or psychotic disorder not otherwise specified. 
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Table 2. Criteria for Dysthymic Disorder 
A. Depressed mood must be present most of the day almost every day for 
at least two years. 
B. Presence, while depressed, of at least two of the following. 
1. Poor appetite or overeating 
2. Insomnia or hypersomnia 
3. Low energy or fatigue 
4. Low self-esteem 
5. Poor concentration or difficulty making decisions 
6. Feelings of hopelessness 
C. During the two-year period never without symptoms for more than two 
months at a time. 
D. No evidence of an unequivocal major depressive disorder during the 
first two years. 
E. Has never had a manic or hypomanic episode. 
F. Not superimposed on a chronic psychotic disorder, such as 
schizophrenia or delusional disorder. 
G. It cannot be established that an organic factor initiated and maintained 
the disturbance. 
hopelessness or helplessness, preoccupation with depressive thoughts, and 
hallucinations. It is important to note that hopelessness has been implicated as 
the most important factor linking depression to suicidal behavior.14 Finally, the 
somatic symptoms of depressive illness may include fatigue, constipation, 
reduced or increased appetite, sleep with early morning awakenings or 
insomnia, and reduced libido. 
However, Stern and Bachman5 pointed out that the DSM III-R criteria for 
major depressive syndrome may be difficult to apply to patients who are 
suffering from poststroke depression. This is due to the difficulty in classifying 
symptoms secondary to stroke, such as of aphasia, dysprosody, and other 
cognitive impairments (Le., feelings of worthlessness) or may be masked or 
mimicked by the known neurobehavioral consequences of the stroke itself (Le., 
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poor concentration, apathy, psychomotor agitation, or retardation). Clothier and 
Grotta1 also noted that diagnostic criteria for major depression according to the 
DSM III may be invalid in patients who have had a stroke because the 
structured brain lesion may lead to somatic dysfunction or decreased ability to 
report symptoms. Furthermore, Herrmann and Wallesch16 pointed out that it is 
difficult to determine whether symptoms, such as loss of weight, loss of 
appetite, or sleeping disorders, are actually consequences of depression or 
whether they are caused by the stroke itself. 
On the other hand, several groups of researchers have shown that it is 
appropriate to classify poststroke depression according to DSM-III criteria. 
Fedoroff et al17 studied 205 acute stroke patients and found that psychological 
and somatic symptoms of depressive illness were strongly associated with low 
mood but were relatively uncommon among stroke patients without a mood 
disturbance. Therefore, they concluded that DSM-III criteria for major 
depression appear to be generally appropriate among patients who have 
poststroke depression. Studies by Robinson, Starr, Kubos, and Price18 and 
Lipsey et al19 showed similar results that concluded depression associated with 
stroke may have symptoms of either major or minor depression that meet DSM-
III criteria. Specifically, a study by Robinson et al20 found that a rate of 
misdiagnosis based on DSM-III criteria is small, ranging from underdiagnosis by 
5% to overdiagnosis by 2%. This would suggest symptoms of depression as 
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described by the DSM-III may be correctly applied to patients who have 
poststroke depression, but this remains controversial as mentioned previously. 
Robinson, Lipsey, and Price21 noted that in more than 50% of patients who 
had suffered a stroke, symptoms of major depression include sadness, 
anxiety/restlessness, loss of energy, decreased appetite and weight loss, initial 
and tertiary insomnia, social withdrawal, and irritability. Furthermore, the 
primary characteristics of minor depression (dysthymia) in these patients 
include sadness and anxiety/restlessness. Ross and Rush22 also presented 
several "bedside clues" for recognizing and diagnosing depression specifically 
in patients with brain damage. They suggested initial signs may include a poor 
or erratic recovery, deterioration from a previously stable neurological condition, 
and pathological laughter and crying in the absence of pseudobulbar palsy. 
However, as noted previously, patients suffering from poststroke 
depression often go unrecognized. Freeling et al23 reported that those patients 
with unrecognized depression showed less evidence of overt depressed mood 
(reported sadness, depression, or crying), were less aware of being ill or 
depressed, and responded in the short-term with better or worse mood. They 
also improved or worsened in response to environmental changes and regarded 
depressed mood as distinct from the normal experience of depression or 
sadness. Patients with unrecognized depression more fr~quently had a current 
illness of more than a year and were more likely to have a concurrent 
nonpsychiatric medical illness, such as stroke. 
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Several researchers have found it is likely that numerous factors may 
contribute to the severity of poststroke depression. Robinson, Boldue, Kubos, 
Starr, and Price24 found that lower social functioning scores measured using a 
28-item Social Functioning Exam, as well as higher functional physical 
impairment, higher cognitive impairment, and younger age correlated with 
increased severity of depression. Their finding that younger age was 
associated with more severe depression was thought to result from the greater 
disruption that stroke causes in the lives of younger compared to older 
individuals. A two-year longitudinal study of poststroke mood disorders by 
Robinson, Starr, Lipsey, Rao, and Price25 showed similar results. These results 
suggest that during the acute hospitalization of patients who had suffered a 
stroke, the most severe impairments in functional physical activity or cognition 
were associated with the greatest severity of depression. Furthermore, they 
found patients with the poorest quality of social supports and younger patients 
tended to be more depressed than those with better social supports or older 
age. Sinyor et al4 stated that physical or cognitive impairment may interact in a 
multifactoral manner with loss of social or vocational activities, personality 
factors, such as coping strategies, and family and social support which 
consequently may lead to depression. 
On the other hand, Feibel and Springer? reported that depression status 
was not significantly related to age, sex, marital or cognitive status, side of 
brain involvement, independence in activities of daily living (ADLs) and 
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ambulation (physical impairment), or change in residence. In addition, Walker 
et al26 and Magni et al27 found older and lower social class patients were more 
depressed. Herrmann and Wallesch 16 also noted that neither the severity of 
handicap nor neurological symptoms, such as the presence and degree of 
hemiparesis, hemisensory deficit, and visual field defects have an influence on 
the development and severity of depressive changes in the initial and postacute 
periods after stroke. 
The results of various studies indicate there is also no difference in the 
frequency of depression between aphasic and nonaphasic patients with left 
hemisphere stroke.10.28 A question remains as to whether or not aphasia is 
linked to the severity of depression. After detailed analysis of aphasic patients, 
Robinson and Benson29 and Gainotti30 reported both a higher incidence and 
significantly more severe depression with nonfluent aphasia syndromes (Broca's 
and/or global aphasia). After a review of the literature, Swindell and 
Hammons1o stated, "Aphasia does not appear to be a critical variable for 
predicting the severity of depression." 
There are several methods available to assess severity and diagnose 
depression in individuals who have had a stroke. One of the methods used is 
self-rating scales. Two of the most commonly used are the Zung Self-Rating 
Depression Scale (SDS)31 and the Beck Depression Inventory (BDI).32 The 
SDS is a 20-item scale completed by the patient without assistance. It is 
designed to quantify depression by measuring affective, psychological, and 
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somatic features of the disorder.10 The BDI is an interview-assisted 
questionnaire consisting of 21 questions designed to measure the behavioral 
manifestations of depression.33 Herrmann and Wallesch 16 noted that these 
methods of assessment may be difficult to use in patients with aphasia who 
suffer from more than mild comprehension impairment. 
In order to more effectively assess aphasic patients, self-rating scales have 
been developed that rely on intact nonverbal or language compensatory 
capacities. An example is the Visual Analogue Mood Scale.16 Stern and 
Bachman 15 used a modification of this scale to assess dysphoric mood in 
patients who had suffered a stroke. This scale consisted of a 100 mm. line with 
words and cartoon faces indicating "happy" and "sad" at each end. The line 
had a vertical rather than a horizontal line to preclude bias due to right or left 
side hemispatial neglect. The score on this scale was measured by the number 
of millimeters from the "happy" end as rated by the patient. 
Another method of diagnosing depression is observer or clinician rating 
scales. Examples include the Hamilton Rating Scale for Depression (HRS),34 
the Cornell Scale for Depression,35 and the Present State Exam (PSE).36 The 
common feature of these assessments is they depend on information provided 
by the patient for evaluation by a third party such as a clinician.16 Unlike the 
other scales, the HRS was originally designed for use with patients already 
diagnosed as depressed.10 
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Finally, a blood test called the dexamethasone suppression test (OST) has 
been used as an objective means to diagnose depressed individuals. Swindell 
and Hammons1o described this test as " ... a test of neuroendocrine function 
which measures suppression of cortisol secretion in response to an exogenous 
cortisol, dexamethasone. II They went on to explain that cortisol production is 
higher in depressed than in nondepressed individuals, and fails to suppress 
normally after the administration of dexamethasone which would indicate a 
positive test. Several studies indicate the DST is highly specific for depression 
in non-neurologically impaired populations.37,38 However, Finklestein et al39 
reported the prevalence of abnormal DST findings to be greater in stroke (52%) 
vs. non-neurologically impaired, disabled control patients (8%). Therefore, the 
DST has limited use in diagnosing poststroke depression. 
In summary, defining poststroke depression is not an easy task for 
clinicians or researchers alike. Herrmann and Wallesch 16 noted that any study 
concerned with the issue of investigating emotional-affective changes following 
stroke is faced with two problems. First, patients who have h'ad a stroke not 
only suffer from mood disorders, but there may be a wide array of neurological 
and neuropsychological deficits present which tend to mask the symptoms of 
poststroke depression. The second problem is that depressive changes may 
have to be investigated by observer's ratings or by nonverbal means of 
exploration rather than a verbal interview approach in dealing with patients who 
have aphasia, a qualitatively and quantitatively important subgroup of stroke 
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victims. Together, these issues contribute to methodological problems 
concerning the measurement of depressive alterations following stroke. 
CHAPTER 3 
THE ETIOLOGY OF POSTSTROKE DEPRESSION 
In early articles on rehabilitation, authors mentioned that depression was 
understandable in light of the patient's disability and constituted an emotional 
reaction to his or her disability.40 Tanner and Gerstenberger41 stated, " ... 
depression is a normal and predictable reaction to loss. Depression should not 
be considered abnormal or pathological." Benson42 also reported that 
depressive changes must not be interpreted as pathologic and that some forms 
of reactive depression indicate progress and may actually be a "healthy sign." 
Robins43 suggested that the frequency of poststroke depression is no different 
than after other medical illnesses and that the cause of the depression is a 
"non-specific" psychological effect of medical illness. 
However, there is research that suggests otherwise. Folstein et al44 studied 
20 patients who had suffered a stroke and 10 patients with orthopaedic 
disability with the same level of disability in both groups. They found that more 
of the stroke patients than orthopaedic patients were depressed (45% vs. 10%, 
respectively) which led them to conclude that mood disorder is a more specific 
complication of stroke than simply a normal response to motor disability. The 
results of a study by Stern and Bachman 15 also suggested that dysphoric mood 
15 
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following stroke is not merely an expected grief reaction to functional 
impairment. 
Fedoroff et al45 studied 44 patients who had a stroke, 25 patients with 
myocardial infarction, and 12 patients with acute spinal cord injury, all of whom 
met criteria for major depression as defined by DSM-1I1.12 Significantly more 
patients with poststroke depression were found to have generalized anxiety 
disorder compared to depressed patients with spinal cord injury or myocardial 
infarction. The authors concluded that the etiology of poststroke depression 
may be different from that associated with myocardial infarction or spinal cord 
injury and that it is more than a psychological reaction to stress. 
One of the major theories which attempts to explain the mechanisms 
underlying a major depressive episode is based on a neuropharmacology 
model. Although several neurotransmitters have been implicated in depression, 
the catecholamine, norepinephrine, is most often discussed to exemplify this 
model. 10 Schildkraut46 first proposed the catecholamine hypothesis of affective 
disorders which suggests that some, if not all, depressions are associated with 
an absolute or relative deficiency in norepinephrine (most notably) at 
functionally important adrenergic receptor sites in the brain. This hypothesis 
may be true for patients with poststroke depression as Robinson et al47 reported 
that brain stem catecholamines are depleted after experimentally induced 
cortical cerebral infarction in the rodent. A further laboratory experiment by 
Robinson48 demonstrated that focal cortical lesions in rats produce widespread 
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but asymmetrical depletion of catecholamine concentrations depending upon 
which hemisphere of the brain is injured. 
Bryer et al49 suggested another hypothesis for the etiology of poststroke 
depression within the neuropharmacology model. The preliminary study 
measured monoamine metabolites in the cerebrospinal fluid (CSF) of three 
groups: 1) patients with poststroke depression, 2) non-depressed patients with 
acute stroke lesions, and 3) non-depressed patients without stroke lesions. 
Patients with poststroke depression had a significantly lower concentration of 
CSF 5-hydroxyindoleacetic acid (5-HIAA, a serotonin metabolite) than the other 
two groups. These findings suggest that poststroke depression may be 
mediated by serotonergic mechanisms. 
The second major model used to explain the etiology of depression is a 
neuroendocrine model as described by Swindell and Hammons. 10 They stated, 
"It is well established that abnormalities in the metabolism of hormones along 
the hypothalamic-pituitary-adrenal (HPA) axis and pituitary-thyroid axis occur in 
depressive disorders." Normally, the hormone cortisol is released by the 
adrenal glands in an attempt to relieve the physiologic effects of stress by 
inhibiting the release of corticotrophin-releasing-factor (CRF) and 
adrenocorticotrophic hormone (ACTH) which are both secreted in reaction to 
physiologic or psychogenic stress. There exists a negative feedback effect 
where elevated levels of cortisol inhibit additional production of cortisol. 
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This neuroendocrine model proposes that in depression there is a 
breakdown in this complex closed-loop negative feedback system.10 Cortisol is 
elevated in a large percentage of depressed patients and fails to suppress 
when challenged by an exogenous cortisol, dexamethasone. Clinically, this is 
tested by the dexamethasone suppression test (DST), a test of neuroendocrine 
function. Unfortunately, biologic tests such as the DST have limited utility in 
diagnosing poststroke depression.11 
The third and final model which attempts to explain the etiology of 
poststroke depression is based on neuroanatomy. This hypothesis suggests 
that infarction of the brain can produce a mood disorder. It appears that 
normally, the left hemisphere regulates positive emotions and the right 
hemisphere regulates negative emotions.10 The maintenance of normal mood 
depends on both hemispheres functioning properly to keep each other in proper 
balance. The individual with unilateral brain damage loses the inhibition 
provided by the damaged hemisphere, which results in the abnormal activation 
of the contralateral hemisphere.10 In general, the frequency and severity of 
depression has come to be regarded as greater with left than right hemisphere 
lesions.4,10,15,20,25 
Ross and Rush22 proposed a neuroanatomical theory which views 
depression as neither a right nor left hemisphere syndrome, but a disorder that 
involves the participation of both hemispheres. They found major depression is 
more highly associated with an infarct of the left hemisphere whereas minor 
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depression is associated more with right hemisphere damage. According to 
their theory, a stroke of the left hemisphere would make the verbal-cognitive 
apparatus inaccessible for the expression of the affective-expressive sets (intact 
right hemisphere) and have a higher association with major depressive illness. 
On the other hand, stroke in the right hemisphere would leave the verbal-
cognitive apparatus available (intact left hemisphere) to describe emotional 
sets, but the emotional set would be unstable in a manner similar to that seen 
in minor depressive illness. They concluded that disruptions of normal right-left 
hemispheric interactions playa prominent role in the pathophysiology of 
poststroke depression. 
Robinson et al20 presented similar findings within the neuroanatomical 
model. They studied 36 right-handed patients with single stroke lesions of 
either the right or left hemisphere with no predisposing factors for psychiatric 
disorder. They found that the severity of depression was significantly increased 
in patients with left anterior lesions as opposed to any other lesion location. 
Specifically, major depressive illness was highly associated with lesions of the 
left frontal lobe or left basal ganglia and minor depressive illness (dysthymia) 
was associated with either right or left occipital or parietal lesions. In addition, 
the severity of depression correlated significantly with proximity of lesion on a 
CT scan to the frontal pole in the left anterior group. However, the right 
hemisphere lesion group showed the reverse trend where patients with right 
posterior lesions were more depressed than patients with right anterior lesions, 
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who were more often inappropriately cheerful and apathetic. In an attempted 
replication of the previous study, Sinyor et al4 supported the association 
between lesion location and severity of poststroke depression with left 
hemisphere damage. However, unlike Robinson et al,20 they found an anterior 
location of lesion was not associated with severity of depression after right brain 
damage. 
Robinson et af5 also studied a group of 103 patients with stroke over the 
first two years after infarction to determine the variables which are associated 
with the development of depression. They, too, reported that the closer the 
lesion to the left frontal pole, the more severe the depression and in the right 
hemisphere, lesions farthest from the frontal pole are associated with the most 
severe depression. They also found that the strength of the relationship 
between lesion location and severity of depression in left hemisphere lesion 
patients did not change over the first six months poststroke, while in patients 
with right hemisphere lesions, the direction of the correlation reversed. These 
findings suggest there may be some dynamic changes occurring in the right 
frontal brain region over time and are consistent with the suggestion of Ross 
and Rush22 that this brain region may play an important role in the regulation of 
mood. Still, there is no known neuroanatomy or neurophysiology to account for 
the importance of the frontal lobe in affect.20 
In conclusion, it is likely that the ultimate etiology of poststroke depression 
is a complex interaction of neurochemical, neuroendocrine, metabolic, and 
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cognitive alterations after stroke, as well as differences in both inter- and intra-
hemispheric cerebral specialization of emotional processing. 15 Robinson et al25 
stated, "Poststroke mood disorders don't have a single etiology but rather, 
patients with different locations of brain injury and perhaps at different time 
points poststroke may have different etiologies for their mood disorders." 
Although the pathogenic mechanism is not specifically isolated, research 
strongly suggests that depression in the initial and post-acute phase following 
stroke (at least left hemisphere stroke) is biologically caused. 16 The nature and 
course of poststroke depression does not appear to be a simple reaction to the 
emotional trauma of physical and intellectual impairment. 
CHAPTER 4 
THE EFFECTS OF POSTSTROKE DEPRESSION ON REHABILITATION 
One of the most important issues regarding poststroke depression is the 
potential negative impact of depression on patients' participation in the 
rehabilitation process and the associated rehabilitation outcome.2 A primary 
goal of rehabilitation is the restoration of maximal independence in activities of 
daily living (ADLs) and mobility within one's physical and mental abilities. 
According to Schubert et al,33 emotional and neuropsychologic disturbances 
may cause greater incapacity and impairment to rehabilitation efforts than 
physical deficits, such as paralysis, sensory loss, and imbalance which are 
often observed as sequelae of stroke. Overall, the majority of the literature 
suggests that depression will be associated with decreased physical functional 
ability in a poststroke population.33 
Although it seems that reduced functioning after stroke does not account 
for the origin of depression, once the depression appears, there is a reduction 
in functional capacities.1 Several authors have hypothesized why this is so. 
Wells, Stewart, and Hays50 found there was greater functional disability in 
depressed patients with stroke than in non-depressed patients with stroke. 
They suggested this may result from the interactive effects of depression and 
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stroke on physical ability. Similarly, Robinson, Lipsey, Rao, and Price51 
concluded that, if present, depression interacted with disability and had negative 
effects on medical and psychosocial rehabilitation. Schubert, et al.33 suggested 
that depression lowers functional ability by increasing fatigue and hopelessness 
and decreasing motivation. It has also been noted that depressive symptoms, 
such as changes in eating and sleeping patterns and activity levels, exacerbate 
health problems in a population that is more prone to health problems given 
their medical history.1o 
It has been suggested that the degree of physical impairment is higher with 
more severe depression. In their study of 21 patients with stroke, Schubert et 
al33 found that physical function after stroke is poorer with higher levels of self-
reported depression as measured by the Beck Depression Inventory. Pariikh et 
al52 studied 103 stroke patients for two years and found a positive correlation 
between severity of depression and impairment in daily living that was maximal 
at six months after stroke and declined over the next 18 months but still 
remained. Robinson et al25 also found that over the first six months follow-up, 
there was a continuous increase in the strength of the association between 
functional physical impairment and severity of depression. Additionally, Clothier 
and Grotta1 noted the more severe the depression, the more impaired the 
patient, and the worse the outcome. They concluded this can be considered a 
red flag for the clinician in that depressive illness should be considered in a 
patient who is failing to progress in rehabilitation.1 
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Patients with poststroke depression showed similar improvements in 
functional status following short-term rehabilitation as compared to non-
depressed patients.2 Overall, the depressed patients had greater functional 
impairment at both admission to and discharge from an acute rehabilitation 
hospital than the non-depressed group. However, both groups improved in 
functional status from admission to discharge, and self-rated depression scores 
were not related to length of stay in the rehabilitation unit. The authors 
concluded that poststroke depression did not appear to undermine the process 
of formal rehabilitation. They hypothesized this was because, while in-hospital, 
patients were exposed to an intensive rehabilitation program in which their 
participation was actively sought and reinforced. 
However, Sinyor et al2 also found that poststroke depression may exert a 
negative impact on long-term rehabilitation outcome. The functional status of 
25 patients was reevaluated by both occupational and physical therapy six 
weeks after discharge. Although there were no significant group differences in 
aT ratings, according to the PT ratings, the depressed patients showed 
reductions in functional status significantly different than the relative stability 
shown by the non-depressed group. This led the authors to conclude that 
poststroke depression apparently has a negative effect on rehabilitation gains 
after discharge. The authors hypothesized that this may be because following 
discharge and in the absence of active encouragement from clinicians, the 
poststroke depression may have interfered with the patient's personal initiative 
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to engage in the recommended therapeutic exercises and activities. This 
reduced activity may have resulted in a loss of the gains achieved while in-
hospital. 
Similar findings have also been reported regarding long-term effects on 
functional recovery. Morris, Raphael, and Robinson3 indicated that patients with 
poststroke depression fared worse in functional, physical, and cognitive 
recovery from stroke than non-depressed patients when reassessed 14 months 
after the initial assessment. Also, Pariikh et al9 found that although major 
depression had spontaneously remitted in most patients by two years after the 
stroke, the formerly depressed patients had not achieved complete ADL 
recovery as compared with patients who had not suffered poststroke 
depression. These studies demonstrate a negative impact of poststroke 
depression on long-term recovery in activities of daily living after stroke. 
The restoration of maximal independence in ADLs and mobility as a 
primary goal of rehabilitation is a narrow interpretation of the complete 
rehabilitation process. A broader perspective includes the degree to which 
survivors of stroke are restored to the level of social functioning normal to them 
before stroke.53 According to Labi et al,53 various studies have suggested that 
social reintegration of patients who have had a stroke is possibly the most 
difficult and problematic phase of rehabilitation. 
Labi et al53 studied 121 survivors of stroke who were not necessarily 
suffering from poststroke depression. In this sample, the authors found about 
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half of those who could ambulate independently had not experienced any 
change in their mode of transportation or had not had any falls; nevertheless, 
decreased their socialization outside the home. The data also revealed that 
about one third of the survivors who had resumed most or all of their household 
responsibilities did not resume their social activities they enjoyed prior to their 
stroke. The authors concluded that many survivors of stroke do not return to a 
normal social life even after physical disability has ceased to be a serious 
obstacle. 
Feibel and Springer? conducted a study to examine the relationship of 
poststroke depression and the resumption of premorbid social activities. They 
studied 91 patients with stroke, 24 of whom had poststroke depression. The 
data showed that patients with poststroke depression lost 67% of their prior 
social activities, while patients whom nurses did not rate as depressed lost only 
43% of their prior social activities. The authors concluded that although the 
association between lost activities and depression does not imply a causal 
relationship, poststroke depression significantly correlated with the failure to 
resume social activities after stroke. 
Other studies have been done to examine psychosocial functioning after 
stroke. Astrom, Asplund, and Astrom6 concluded that the interaction of major 
depression early after stroke, functional disability, and an impaired social 
network reduce life satisfaction for the long-term survivors of stroke. Starkstein 
and Robinson54 also claimed that once poststroke depression occurs, it 
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interacts with physical and intellectual impairment to reduce the patient's future 
social functioning. Finally, Wells et also found that depressive disorder or 
symptoms were associated with poorer physical, social, and role functioning 
than in patients with no chronic medical or psychiatric condition. 
Overall, poststroke depression has been linked to an inability to maintain 
functional gains, continue to improve, and resume social activities after the 
acute rehabilitation phase. These negative effects appear to be most significant 
to long-term outcome as Sinyor et al2 found that patients with poststroke 
depression appear to make similar gains during the formal rehabilitation process 
as compared to non-depressed patients. Bruckbauer11 noted that because of 
the long-term effects, health professionals, such as physical therapists, who 
continue to see patients in their home after stroke need to be aware of 
poststroke depression as a possible cause when the patients have difficulty 
making the transition from hospital to home care. 
CHAPTER 5 
TREATMENT OF POSTSTROKE DEPRESSION 
Feibel and Springer7 and Robinson, Lipsey, and Price21 agreed that the 
treatment of depression is one of the greatest unmet needs of stroke survivors. 
Feibel and Springer7 evaluated 91 patients six months poststroke and found 24 
patients to be significantly depressed. However, less than 5% had received 
treatment. Tille,..a offered four reasons as to why poststroke depression is often 
left untreated. First, there may be an assumption that simply having a physical 
disability from a stroke is the cause of the depression. Secondly, one may 
assume that since the stroke itself is generally irreversible, so is the depression. 
Thirdly, there may be the assumption that because the etiology of the 
depression is known to result from the stroke, there is no need to treat the 
depression. Finally, there may be an assumption that the depression will 
resolve in time, so there is no need for specific intervention. 
However, research suggests early identification and treatment of poststroke 
depression is essential. It has been reported that effective and rapid treatment 
of poststroke depression may enhance stroke rehabilitation and speed up 
functional recovelf,3,8 both during the hospital stay and over the two-year 
recovery period.9 Several treatments have been used when treating patients 
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with poststroke depression including pharmacotherapy, electroconvulsive 
therapy (ECT), and psychotherapy. 
Pharmacotherapy 
The first-line pharmacologic treatment of depressive illness is the tricyclic 
antidepressants (TCAs) including amitriptyline, nortriptyline, imipramine, 
desipramine, and doxepin.1 The more commonly prescribed TCAs function by 
blocking the re-uptake of amines into the presynaptic terminal thereby 
prolonging the effects of serotonin, norepinephrine, and dopamine at the 
synapse. 1,6 Lipsey et al55 reported a double-blind placebo-controlled study of 
the effectiveness of nortriptyline for major depressive illness in poststroke 
patients. There was clear improvement in the patients receiving nortriptyline. 
Due to their side effects, tricyclic antidepressants may have limited use in 
patients with poststroke depression. The side effects of principal importance in 
this population are orthostasis and anticholinergic effects, such as blurred 
vision, constipation, urinary retention, and central anticholinergic delirium.1,6 
Amitriptyline is the agent associated with the highest anticholinergic activity. 
Organically impaired patients are more sensitive to the development of 
anticholinergic delirium; thus, amitriptyline may prove to be an inappropriate 
choice when treating poststroke depression.1 
TilierB noted some further limitations in the use of TCAs to treat poststroke 
depression. The author noted TCAs may have adverse antimuscarinic effects, 
potential to cause confusion with sedation, and potential cardiovascular toxicity. 
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The cardiovascular toxicity may be a particular risk for those with stroke and 
cardiovascular disease, who may be especially vulnerable to postural 
hypotension, cardiac conduction alterations, or arrhythmias. 
A second generation of antidepressant agents, such as trazodane, 
fluoxetine, amoxapine, maprotiline, and bupropion, has recently become 
available. Reding et al56 found that 200 mg of trazodone per day produced 
improvement on Barthel's ADL scores in poststroke patients who had a clinical 
diagnosis of depression. Depression was measured by the Zung scale, or an 
abnormal dexamethasone suppression test. However, the second-generation 
antidepressants have a variety of non-tricyclic-like side effects, such as 
priapism with trazodone, seizures with maprotiline, extrapyramidal side effects 
with amoxapine, and the extremely long half life of fluoxetine.1 These drugs 
may also cause headaches, nausea, and unacceptable agitation.8 The 
headache and nausea may be especially troublesome in patients with stroke 
since either one may be incorrectly interpreted as a new cerebrovascular event. 
According to Clothier and Grotta,1 these drugs are no more effective than 
tricyclic agents, have the same mechanism of action as the TCAs, and are not 
recommended as first-line agents for poststroke depression. 
Another class of antidepressant drugs that has been successful in the 
treatment of depression is the monoamine oxidase inhibitors (MAOls), including 
isocarboxadine and phencizine sulfate. The MAOls work by blocking the action 
of monoamine oxidase which results in elevated concentrations of serotonin, 
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dopamine, and norepinephrine in brain tissues.1o According to Tiller,s the 
traditional irreversible, non-selective MAOls are limited by two factors, including 
the need for stringent dietary and medication precautions and, in effective 
dosage, they may also cause postural hypotension. Despite these limitations, 
they remain the drug of choice for some clinicians in treating poststroke 
depression because they are tolerated well by many patients.s,1o 
A nontraditional MAOI is moclobemide which is a selective, reversible 
inhibitor of monoamine oxidase A (RIMA). Moclobemide seems to have the 
potential for particular advantages in patients with poststroke depression. Tille~ 
noted it is very well tolerated, has no clinically significant anticholinergic or 
cardiac effects, and does not cause appreciable postural hypotension. It is not 
a sedative, agitation is not a prominent side effect, and it seems to be free of 
clinically significant psychomotor effects. Furthermore, the author pointed out 
that moclobemide has proven efficacy for both endogenous and reactive 
depressions. Tille~ concluded that moclobemide appears to have desirable 
characteristics as an antidepressant for poststroke depression. However, 
research is in progress to investigate whether this view is confirmed by the 
experience of patients. 
Electroconvulsive Therapy 
Electroconvulsive therapy (ECT) has been considered by many clinicians to 
be the most rapid and effective treatment for depression. Eighty to 90% of 
depressed patients show a significant improvement of symptoms, occasionally 
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occurring within days of the initial treatment.10 In functional depression, ECT 
has a record of safety and efficacy but is seldom needed because of the 
effectiveness of antidepressant drugs.1 However, it is useful for major 
depression which is not responsive to antidepressants and in those with high 
suicidal risk.8 According to Tiller,8 ECT may be used to treat severe poststroke 
depression following the initial three months after the stroke. Karlinef7 noted 
that stroke itself is not a contraindication to the use of ECT. 
Murray, Shea, and Conn58 studied 14 patients who had ECT for poststroke 
depression. Twelve of the 14 patients demonstrated improvement following 
ECT. The authors noted that during ECT, one patient with known 
cardiovascular disease developed an arrhythmia. Still, the authors concluded 
that poststroke depression can be safely and effectively treated with ECT. 
Electroconvulsive therapy may have side effects or complications that need 
to be reco-gnized. The most serious is that the convulsion induced by ECT has 
physiologic effects on the cardiac system which may cause death due to 
cardiac complications.1 This is relatively infrequent with a rate of approximately 
one death per 10,000 patients.1o Because of this, careful pretreatment 
screening is needed in stroke patients who often have underlying cardiovascular 
disease. The more frequently reported adverse effects of ECT include 
posttreatment confusion and transient anterograde and retrograde amnesia.1o 
Fink59 noted that although memory disturbance is rarely documented to persist 
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beyond one month after a course of ECT, some patients (particularly the 
elderly) complain of memory problems over longer periods. 
Psychotherapy 
Psychotherapy may be used as an alternative or supplement to 
pharmacotherapy and ECT in the treatment of depressed individuals. Beck, 
Rush, Shaw, and Emery60 developed cognitive-behavioral therapy which is the 
only psychotherapy specifically designed to treat depression. According to 
Swindell and Hammons,10 it is a directive, time-limited therapy that usually 
requires 15 to 25 weekly sessions. The cognitive aspect of the cognitive-
behavioral model views all symptoms of depression as consequences of 
negative thinking patterns. The behavioral component emphasizes increasing 
masterful activity and pleasurable experiences in order to decrease anhedonia 
and social isolation that characterize depression. This therapy differs from 
traditional, psychoanalytic therapy in its problem-solving orientation with 
emphasis on present-day problems and coping skills.10 The therapist also 
assumes an active and collaborative role in therapy to arrive at and test out 
problem solving skills. The cognitive-behavioral technique can only be learned 
in a formal training situation that includes ongoing supervision of the therapist in 
training by a trained cognitive-behavioral therapist.10 
A family-therapy approach has been advocated for the treatment of both 
aphasic patients and their relatives.61 Herrmann62 pointed out that it is unlikely 
that a family system including a patient with aphasia can be described and 
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interpreted in terms of traditional family therapy. Furthermore, based on 
preliminary data on client-centered psychotherapy, Johannsen-Horbach et al63 
argued that the problems of patients with aphasia and their relatives are 
different and that their needs are often opposed to each other. 
Herrmann and Wallesch 16 noted that although there are many possible 
intervention therapies directed at psychosocial counseling and 
psychotherapeutic aid, there are no systematic evaluation studies concerning 
the differential effects and indication of reactive induced poststroke depression. 
The authors stated, "Evaluation and modification of psychotherapeutic 
approaches in view of the requirements of brain-damaged patients and their 
relatives remain important research goals." 
In summary, pharmacotherapy, ECT, and psychotherapy may be used to 
treat depression. Clinically, one should choose a treatment based on the side-
effect profile, tolerance, and ability to monitor the therapy.1 It is especially 
important to consider the side-effects of pharmacotherapy for patients with 
poststroke depression who are undergoing rehabilitation as the side-effects may 
pose problems during therapy (Le., postural hypotension, blurred vision, and 
cardiac conduction alterations) as well as potentially deleterious effects on new 
learning.1 More research in the treatment of poststroke depression needs to be 
done to determine whether therapeutic measures which are appropriate for 




In conclusion, poststroke depression appears to be a prevalent disorder for 
survivors of stroke.2,3,4 Yet, it often goes unnoticed and untreated as part of the 
rehabilitation process. Recently, research has been conducted in an attempt to 
clarify what poststroke depression is, what causes it, how it affects rehabilitation 
efforts, and how it is most effectively treated. 
Clinically, it is important that health care professionals recognize the signs 
and symptoms of poststroke depression. Symptoms may include sadness, 
anxiety/restlessness, loss of energy, decreased appetite and weight loss, 
insomnia, social withdrawal, and irritability.21 Initial signs of poststroke 
depression include a poor or erratic recovery, deterioration from a previously 
stable neurological condition, and pathological laughter or crying in the absence 
of pseudobulbar palsy.22 A patient who is failing to progress in rehabilitation 
should be considered a red flag for depressive illness.1 
Poststroke depression may be an important issue for family members and 
clinicians who provide home health care. This is because poststroke 
depression poses particularly deleterious effects on long-term rehabilitation 
outcome.2 After discharge from a rehabilitation hospital, the patient is no longer 
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actively encouraged by clinicians to perform therapeutic exercises and activities. 
Poststroke depression may interfere with the patient's motivation to do the 
recommended activities which may result in the loss of gains achieved while 
hospitalized. It is important to note that studies in depressive disorders suggest 
a powerful therapeutic effect of exercise.64 Physically active as opposed to 
sedentary individuals have been found to be more extroverted and less 
depressed.65 Still, there is a need for research on the effects of exercise 
specifically on poststroke depression. 
If a clinician or family member suspects depression in a person who had a 
stroke, the individual should be referred for treatment because the depression 
may be potentially reversed. Pharmacotherapy, electroconvulsive therapy 
(ECT), and psychotherapy may be used to treat poststroke depression. If a 
depressed individual is being treated with pharmacotherapy or ECT, it is 
necessary for the clinician to be aware of potential side effects. These include 
postural hypotension, nausea, blurred vision, cardiac conduction alterations, and 
negative effects on new learning wtth-sume pharmacotherapy treatments and 
posttreatment confusion, transient anterograde and retrograde amnesia, and 
cardiac complications with ECT.1,8,10 Only psychotherapy has no side effects. 
However, there are no systematic evaluation studies concerning the differential 
effects of psychosocial counseling and psychotherapeutic aid on poststroke 
depression.18 
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Poststroke depression is a clinical entity that needs to be recognized when 
working with individuals who had a stroke. It is more than a reaction to 
disability; research suggests that depression in the initial and post-acute phases 
following stroke (at least left hemisphere stroke) is biologically caused.16 
Depression has been found to sustain and possibly retard recovery from 
cognitive and physical impairments. 1O According to Clothier and Grotta,1 failure 
to recognize the presence of a depressive illness in the setting of acute 
rehabilitation would be expected to reduce potential return to the community. 
Also, untreated depression impacts the quality of life as life may become quite 
meaningless for the individual with poststroke depression.10 There are effective 
treatments for poststroke depression which may lessen the complexities of the 
readjustment process for survivors of stroke. Overall, the potential reversibility 
of depression emphasizes the importance of early identification of poststroke 
depression.7 
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